BD Launches AI-Powered Surgical Monitor for Blood Pressure Prediction

Becton, Dickinson and Company (BD) has unveiled its latest innovation in patient monitoring technology, marking a significant advancement in surgical care. The company's new HemoSphere Alta system represents the first major product launch from BD's recently acquired advanced patient monitoring business.

AI-Driven Blood Pressure Prediction

The HemoSphere Alta system is equipped with artificial intelligence capabilities designed to predict potentially life-threatening changes in a patient's blood pressure during critical procedures. This predictive functionality aims to enhance patient safety and enable more personalized care during surgeries.

Key features of the system include:

• Tracking of the cerebral autoregulation index, a measure of the brain's ability to maintain stable hemodynamic flow despite blood pressure changes
• Noninvasive oximetry sensor placed on the patient's forehead
• Integration with cardiac output data from an arterial line
• AI-powered predictions of low pressure events and drops in blood oxygen levels

According to BD, the system's ability to provide an index score alongside these predictions can assist clinicians in tailoring therapies more effectively during surgical procedures.

Advanced User Interface and Sterility Features

The HemoSphere Alta monitor boasts a modern touchscreen interface with additional features designed to maintain sterility in the operating room:

• Voice-based commands
• Gesture-based controls
• Hands-free alarm silencing capabilities

These features aim to reduce the risk of contamination during surgical procedures while maintaining ease of use for medical professionals.

Strategic Expansion in Patient Monitoring

The launch of the HemoSphere Alta system comes as a direct result of BD's strategic acquisition of Edwards Lifesciences' hospital monitoring portfolio for $4.2 billion in 2024. This move has significantly expanded BD's presence in the advanced patient monitoring market, positioning the company as a key player in this growing sector of healthcare technology.

The introduction of this AI-powered monitoring system underscores BD's commitment to innovation in patient care and its focus on leveraging advanced technologies to improve surgical outcomes.